Skip to main content

Find Clinical Trials

Home
Conditions
Resectable Prancreas Carcinoma

Clinical trial condition

Resectable Prancreas Carcinoma

Explore clinical trials studying Resectable Prancreas Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Resectable Prancreas Carcinoma trial results

Completed

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

NCT02172976

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Institute of Clinical Cancer Research (IKF), UCT - University Cancer Center, Frankfurt, Germany Frankfurt, Germany

View Trial Details